Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Share-based Compensation (2016 - 2025)

Sonoma Pharmaceuticals has reported Share-based Compensation over the past 16 years, most recently at $24000.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 84.62% year-over-year to $24000.0; the TTM value through Dec 2025 reached $210000.0, up 3.45%, while the annual FY2025 figure was $224000.0, 56.59% down from the prior year.
  • Share-based Compensation for Q4 2025 was $24000.0 at Sonoma Pharmaceuticals, down from $39000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $242000.0 in Q4 2022 and troughed at $13000.0 in Q4 2024.
  • A 5-year average of $98300.0 and a median of $79500.0 in 2024 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 332.14% in 2022 and later crashed 90.71% in 2024.
  • Year by year, Share-based Compensation stood at $56000.0 in 2021, then soared by 332.14% to $242000.0 in 2022, then crashed by 42.15% to $140000.0 in 2023, then crashed by 90.71% to $13000.0 in 2024, then soared by 84.62% to $24000.0 in 2025.
  • Business Quant data shows Share-based Compensation for SNOA at $24000.0 in Q4 2025, $39000.0 in Q3 2025, and $57000.0 in Q2 2025.